GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $270,000 | -71.5% | 7,178 | -69.1% | 0.05% | -77.4% |
| Q2 2020 | $948,000 | +149.5% | 23,233 | +131.8% | 0.23% | +53.3% |
| Q1 2020 | $380,000 | -29.2% | 10,023 | -12.3% | 0.15% | -11.8% |
| Q4 2019 | $537,000 | +10.3% | 11,427 | +0.2% | 0.17% | +1.8% |
| Q3 2019 | $487,000 | +2.5% | 11,409 | -4.0% | 0.17% | -0.6% |
| Q2 2019 | $475,000 | -0.2% | 11,879 | +4.3% | 0.17% | -5.6% |
| Q1 2019 | $476,000 | +16.4% | 11,384 | +6.3% | 0.18% | -9.6% |
| Q4 2018 | $409,000 | -21.9% | 10,713 | -17.9% | 0.20% | -10.0% |
| Q3 2018 | $524,000 | +5.2% | 13,048 | +5.7% | 0.22% | +4.8% |
| Q2 2018 | $498,000 | +4.8% | 12,345 | +3.2% | 0.21% | -18.0% |
| Q1 2018 | $475,000 | +20.9% | 11,961 | +7.9% | 0.26% | +30.8% |
| Q4 2017 | $393,000 | – | 11,090 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |